Common Contracts
2 similar Exclusive License Agreement contracts by Eterna Therapeutics Inc.
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 16th, 2023 • Eterna Therapeutics Inc. • Pharmaceutical preparations
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of this November 14, 2023 (the “A&R Effective Date”), by and between Factor Bioscience Limited, a company organized and existing under the laws of Ireland (“Licensor”), and Eterna Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware (“Licensee”). Licensor and Licensee may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 22nd, 2023 • Eterna Therapeutics Inc. • Pharmaceutical preparations
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of this February 20, 2023 (the “Effective Date”), by and between Factor Bioscience Limited, a company organized and existing under the laws of Ireland (“Licensor”), and Eterna Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware (“Licensee”). Licensor and Licensee may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
